Syndicate This week's upcoming IPO's and secondary offerings

Week of October 1 to October 5, 2024

This Day's Priced Deals: October 3rd, 2018

Symbol

Issuer

Type

Price

Managers

UPWK

Upwork
Upwork
IPO
Priced: $15.00
12.477M
Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Citi, Jefferies, RBC Capital, Stifel & JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GWPH

GW Pharmaceuticals
GW Pharmaceuticals
Secondary
Priced: $158.00
1.9M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley, JPMorgan & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EPZM

Epizyme
Epizyme
Spot Secondary
Priced: $9.00
8.333M
Jefferies

Pricing after close
Deal analysis and details

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KALA

Kala Pharmaceuticals
Kala Pharmaceuticals
Spot Secondary
Priced: $8.25
7.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BofA & Jefferies, Cantor Fitzgerald, Wedbush, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/01 - Monday

Symbol

Issuer

Type

Price

Managers

RXII

RXi Pharmaceuticals
RXi Pharmaceuticals
Secondary
Priced: $.70
21.428M
H.C. Wainwright

Pre-open pricing

Managers: H.C. Wainwright

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/02 - Tuesday

Symbol

Issuer

Type

Price

Managers

UPWK

Upwork
Upwork
IPO
Priced: $15.00
12.477M
Citi,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Citi, Jefferies, RBC Capital, Stifel & JMP Securities

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GWPH

GW Pharmaceuticals
GW Pharmaceuticals
Secondary
Priced: $158.00
1.9M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley, JPMorgan & TD Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EPZM

Epizyme
Epizyme
Spot Secondary
Priced: $9.00
8.333M
Jefferies

Pricing after close
Deal analysis and details

Managers: Jefferies

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KALA

Kala Pharmaceuticals
Kala Pharmaceuticals
Spot Secondary
Priced: $8.25
7.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, BofA & Jefferies, Cantor Fitzgerald, Wedbush, Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/03 - Wednesday

Symbol

Issuer

Type

Price

Managers

GH

Guardant Health
Guardant Health
IPO
Priced: $19.00
12.5M
JPMorgan & BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan & BofA, TD Cowen, Leerink, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KOD

Kodiak Sciences
Kodiak Sciences
IPO
Priced: $10.00
9M
Morgan Stanley & BofA,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & BofA, Chardan

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MLVF

Malvern Bancorp
Malvern Bancorp
Secondary
Priced: $21.00
1.19M
Sandler O'Neill

Pricing after close
Deal analysis and details

Managers: Sandler O'Neill

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ACST

Acasti Pharma
Acasti Pharma
Spot Secondary
Priced: $1.00
16.6M
Oppenheimer

Pricing after close

Managers: Oppenheimer

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IIPR

Innovative Industrial Properties
Innovative Industrial Properties
Spot Secondary
Priced: $40.00
2.6M
Ladenburg,...

Pricing after close

Managers: Ladenburg, Compass Point & BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MNR

Monmouth Real Estate
Monmouth Real Estate
Spot Secondary
Priced: $15.00
8M
BMO Capital,...

Pricing after close
Deal analysis and details

Managers: BMO Capital, JPMorgan & RBC Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SIR

Select Income REIT
Select Income REIT
Spot Secondary
Priced: $18.25
24.918M
Citi,...

Pricing after close

Managers: Citi, BofA & Morgan Stanley, RBC Capital, Wells Fargo

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
WLDN

Willdan Group
Willdan Group
Spot Secondary
Priced: $30.00
1.75M
Wedbush & Roth MKM

Pricing after close

Managers: Wedbush & Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/04 - Thursday

Symbol

Issuer

Type

Price

Managers

ESTC

Elastic
Elastic
IPO
Priced: $36.00
7M
Goldman Sachs & JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs & JPMorgan, Barclays, RBC Capital, BofA, Citi, Jefferies, Canaccord

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ATRC

AtriCure
AtriCure
Secondary
Priced: $30.75
2.5M
JPMorgan & Piper Sandler,...

Pricing after close

Managers: JPMorgan & Piper Sandler, Canaccord, Leerink, Stifel

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
AZRE

Azure Power
Azure Power
Secondary
Priced: $12.50
14.8M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Barclays & HSBC, Societe Generale, JMP Securities, Roth MKM, Janney Montgomery Scott

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HSGX

Histogenics
Histogenics
Spot Secondary
Priced: $.65
26.155M
Canaccord & BTIG

Pricing after close

Managers: Canaccord & BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
KMPH

KemPharm
KemPharm
Spot Secondary
Priced: $3.00
8.333M
RBC Capital,...

Pricing after close
Deal analysis and details

Managers: RBC Capital, Oppenheimer, Janney Montgomery Scott, Roth MKM

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access